Results 1 to 10 of about 1,251,182 (207)

Trends and Disparities in Cardiovascular Death in Sarcoidosis: A Population‐Based Retrospective Study in the United States From 1999 to 2020 [PDF]

Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease
Background Despite significant cardiac involvement in sarcoidosis, real‐world data on death due to cardiovascular disease among patients with sarcoidosis is not well established.
Min Choon Tan, Yong Hao Yeo, Noreen Mirza, Boon Jian San, Jian Liang Tan, Justin Z. Lee, Joanne K. Mazzarelli, Andrea M. Russo   +7 more
doaj   +4 more sources

The Impact of Prostate-Specific Antigen and Gleason Scores on Cardiovascular Death in Prostate Cancer Patients after Radiotherapy or Chemotherapy: A Population-Based Study [PDF]

Reviews in Cardiovascular Medicine
Background: Tumor characteristics are associated with the risk of cardiovascular death (CVD) in cancer patients. However, the influence of tumor characteristics on CVD risk among prostate cancer (PC) patients who have received ...
Huijuan He, Liyu Guo, Peipei Wang, Yuting Yang, Zhenxing Lu, Xiaoping Peng, Tianwang Guan   +6 more
doaj   +2 more sources

Uric acid to albumin ratio is a novel predictive marker for all-cause and cardiovascular death in diabetic patients: a prospective cohort study [PDF]

Frontiers in Endocrinology
BackgroundDiabetes is one of the leading causes of death with an increasing prevalence worldwide. Diabetes-related premature mortality is largely preventable and reversible if identified and managed early.
Shengnan Chen, Shengnan Chen, Ming Zhang, Shouye Hu, Xiaolong Shao, Lin Liu, Zhi Yang, Kai Nan   +7 more
doaj   +2 more sources

Long‐Term Risk of Cardiovascular Death in Patients With Mildly Reduced Ejection Fraction After Acute Myocardial Infarction: A Multicenter, Prospective Registry Study [PDF]

Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease
Background The prognostic implication of mildly reduced ejection fraction (mrEF) after acute myocardial infarction has not been clearly demonstrated.
Hwajung Kim, Kwan Yong Lee, Eun Ho Choo, Byeong‐Hee Hwang, Jin Jin Kim, Chan Joon Kim, Kiyuk Chang, Young Joon Hong, Ju Han Kim, Youngkeun Ahn, Young Choi   +10 more
doaj   +2 more sources

Right Ventricular Function Evaluated by Tricuspid Annular Plane Systolic Excursion Predicts Cardiovascular Death in the General Population

Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, 2019
Background Cardiovascular disease remains a leading cause of death. Right ventricular (RV) function is a strong predictor of outcome in many cardiovascular diseases, but its significance is often neglected.
Daniel Modin, Rasmus Møgelvang, Ditte Madsen Andersen, Tor Biering‐Sørensen   +3 more
doaj   +3 more sources

Long-term follow-up of cardiac arrest survivors: Protocol of the DESAC (Devenir des survivants d’Arrets Cardiaques) study, a French multicentric prospective cohort

Resuscitation Plus, 2023
Background: While the short-term prognosis of cardiac arrest patients - nearly 250,000 new cases per year in Europe - has been extensively studied, less is known regarding the mid and long-term outcome of survivors.
F. Dumas, W. Bougouin, M.C. Perier, N. Marin, C. Goulenok, A. Vieillard-Baron, J.L. Diehl, S. Legriel, N. Deye, P. Cronier, S. Ricôme, F. Chemouni, A. Mekontso Dessap, F. Beganton, E. Marijon, X. Jouven, J.P. Empana, A. Cariou   +17 more
doaj   +1 more source

Azithromycin and the Risk of Cardiovascular Death [PDF]

New England Journal of Medicine, 2012
Although several macrolide antibiotics are proarrhythmic and associated with an increased risk of sudden cardiac death, azithromycin is thought to have minimal cardiotoxicity. However, published reports of arrhythmias suggest that azithromycin may increase the risk of cardiovascular death.We studied a Tennessee Medicaid cohort designed to detect an ...
Richard K, Albert, John, Connett, Prescott G, Woodruff   +2 more
openaire   +8 more sources

Role of Vitamin K-Dependent Factors Protein S and GAS6 and TAM Receptors in SARS-CoV-2 Infection and COVID-19-Associated Immunothrombosis

Cells, 2020
The vitamin K-dependent factors protein S (PROS1) and growth-arrest-specific gene 6 (GAS6) and their tyrosine kinase receptors TYRO3, AXL, and MERTK, the TAM subfamily of receptor tyrosine kinases (RTK), are key regulators of inflammation and vascular ...
Anna Tutusaus, Montserrat Marí, José T. Ortiz-Pérez, Gerry A. F. Nicolaes, Albert Morales, Pablo García de Frutos   +5 more
doaj   +1 more source

Proteomic and phosphoproteomic analyses of myectomy tissue reveals difference between sarcomeric and genotype-negative hypertrophic cardiomyopathy

Scientific Reports, 2023
Hypertrophic cardiomyopathy (HCM) is a genetically heterogenous condition with about half of cases remaining genetically elusive or non-genetic in origin.
Ramin Garmany, J. Martijn Bos, Surendra Dasari, Kenneth L. Johnson, David J. Tester, John R. Giudicessi, Cristobal dos Remedios, Joseph J. Maleszewski, Steve R. Ommen, Joseph A. Dearani, Michael J. Ackerman   +10 more
doaj   +1 more source

Growth Arrest-Specific Factor 6 (GAS6) Is Increased in COVID-19 Patients and Predicts Clinical Outcome

Biomedicines, 2021
Background: Growth arrest-specific factor 6 (GAS6) and the Tyro3, AXL, and MERTK (TAM) receptors counterbalance pro-inflammatory responses. AXL is a candidate receptor for SARS-CoV-2, particularly in the respiratory system, and the GAS6/AXL axis is ...
Albert Morales, Silvia Rojo Rello, Helena Cristóbal, Aida Fiz-López, Elisa Arribas, Montserrat Marí, Anna Tutusaus, Paloma de la Cal-Sabater, Gerry A.F. Nicolaes, José T. Ortiz-Pérez, David Bernardo, Pablo García de Frutos   +11 more
doaj   +1 more source